1 / 7
文档名称:

磺胺二甲嘧啶片SulfadimidineTablets.doc

格式:doc   大小:87KB   页数:7页
下载后只包含 1 个 DOC 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

分享

预览

磺胺二甲嘧啶片SulfadimidineTablets.doc

上传人:蓝天 2022/6/7 文件大小:87 KB

下载得到文件列表

磺胺二甲嘧啶片SulfadimidineTablets.doc

相关文档

文档介绍

文档介绍:磺***二甲嚅喘片(Sulfadimidine Tablets)
磺***二甲「密嚏片(sulfadimidine tablets)
本品主要成份为:磺***:n - (4,6 -二*** -2 - 口密啜基)-4 -氨基苯磺 Therefore, patients with liver function impairment should avoid systemic application of sulfa drugs.
renal damage. Crystallization can occur urine, hematuria and urinary tube, should be more water during the application of the product, to maintain a high urine flow, if the application of this product at a high dose, long course of treatment, in addition to the water should be taken to prevent the adverse reaction of sodium bicarbonate. Dehydration, shock and elderly patients using this may cause kidney damage, or to avoid the use of this product should be used with caution. Patients with renal hypofunction should not use this product.
of furosemide, sulfones, thiazide diuretics, sulfonylurea, carbonic anhydrase inhibitors present in allergic patients allergic to sulfa drugs can.
the following conditions should be used with caution in patients with G-6PD deficiency, hematoporphyria.
attention should be paid during the treatment
Whole blood examination is especially important for patients who receive a longer course of treatment.
Routine urine examination during treatment (routine urine examination every 2~3 days) to discover the possible crystallization of urine during long course or high dose treatment.
Liver and renal function tests.
[pregnant women